156 related articles for article (PubMed ID: 18854285)
1. A case of HIV-negative primary effusion lymphoma treated with bortezomib, pegylated liposomal doxorubicin, and rituximab.
Siddiqi T; Joyce RM
Clin Lymphoma Myeloma; 2008 Oct; 8(5):300-4. PubMed ID: 18854285
[TBL] [Abstract][Full Text] [Related]
2. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
3. [Prolonged survival in a patient with human herpesvirus-8-negative primary effusion lymphoma after combination chemotherapy with rituximab].
Suzuki K; Ino K; Sugawara Y; Mizutani M; Sekine T; Katayama N
Gan To Kagaku Ryoho; 2008 Apr; 35(4):691-4. PubMed ID: 18408447
[TBL] [Abstract][Full Text] [Related]
4. Human Herpesvirus 8-Unrelated Primary Effusion Lymphoma-Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone.
Shin J; Lee JO; Choe JY; Bang SM; Lee JS
Cancer Res Treat; 2017 Jan; 49(1):274-278. PubMed ID: 27283030
[TBL] [Abstract][Full Text] [Related]
5. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
[TBL] [Abstract][Full Text] [Related]
6. Multiple remissions of extracavitary primary effusion lymphoma treated with a single cycle of liposomal doxorubicin in a patient infected with HIV.
Chen J; Mehraj V; Szabo J; Routy B; Michel RP; Routy JP
Curr Oncol; 2018 Dec; 25(6):e592-e596. PubMed ID: 30607128
[TBL] [Abstract][Full Text] [Related]
7. Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
Shah NN; Harrison N; Stonecypher M; Frank D; Amorosa V; Svoboda J
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):e157-60. PubMed ID: 25027567
[No Abstract] [Full Text] [Related]
8. Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.
Coiffier B; Osmanov EA; Hong X; Scheliga A; Mayer J; Offner F; Rule S; Teixeira A; Walewski J; de Vos S; Crump M; Shpilberg O; Esseltine DL; Zhu E; Enny C; Theocharous P; van de Velde H; Elsayed YA; Zinzani PL;
Lancet Oncol; 2011 Aug; 12(8):773-84. PubMed ID: 21724462
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.
Ruan J; Martin P; Furman RR; Lee SM; Cheung K; Vose JM; Lacasce A; Morrison J; Elstrom R; Ely S; Chadburn A; Cesarman E; Coleman M; Leonard JP
J Clin Oncol; 2011 Feb; 29(6):690-7. PubMed ID: 21189393
[TBL] [Abstract][Full Text] [Related]
10. Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma.
Kumode T; Ohyama Y; Kawauchi M; Yamaguchi T; Miyatake J; Hoshida Y; Tatsumi Y; Matsumura I; Maeda Y
Leuk Lymphoma; 2013 Sep; 54(9):1947-52. PubMed ID: 23278643
[TBL] [Abstract][Full Text] [Related]
11. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma presenting with cardiac tamponade: A case report.
Kim HJ; Lee K; Yoon CH; Bang SM
Medicine (Baltimore); 2017 Oct; 96(43):e8010. PubMed ID: 29068981
[TBL] [Abstract][Full Text] [Related]
12. CD20-positive plasmablastic lymphoma with excellent response to bortezomib combined with rituximab.
Yan M; Dong Z; Zhao F; Chauncey T; Deauna-Limayo D; Wang-Rodriguez J; Liu D; Wang HY; Pilz R
Eur J Haematol; 2014 Jul; 93(1):77-80. PubMed ID: 24528507
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma.
Orciuolo E; Buda G; Pelosini M; Petrini M
Br J Haematol; 2010 Mar; 148(5):810-2. PubMed ID: 19919649
[No Abstract] [Full Text] [Related]
14. Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).
Ribrag V; Gisselbrecht C; Haioun C; Salles G; Golfier JB; Ertault M; Ferme C; Briere J; Brice P; Mounier N
Cancer; 2009 Oct; 115(19):4540-6. PubMed ID: 19593797
[TBL] [Abstract][Full Text] [Related]
15. Management and Outcomes of HIV-Associated Primary Effusion Lymphoma: A Single Center Experience.
Gupta A; Sen S; Marley E; Chen W; Naina HV
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S175-80. PubMed ID: 27521315
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma.
Craig M; Hanna WT; Cabanillas F; Chen CS; Esseltine DL; Neuwirth R; O'Connor OA
Br J Haematol; 2014 Sep; 166(6):920-8. PubMed ID: 25039282
[TBL] [Abstract][Full Text] [Related]
17. Solid variant of primary effusion lymphoma in successfully treated HIV infection: a case report.
Mylona E; Baraboutis IG; Georgiou O; Rondogianni D; Lekakis LJ; Papastamopoulos V; Apostolidis I; Skoutelis AT
Int J STD AIDS; 2008 Aug; 19(8):570-2. PubMed ID: 18663051
[TBL] [Abstract][Full Text] [Related]
18. Rare primary effusion lymphoma associated with HHV-8 in Japan.
Ikebe T; Amemiya Y; Saburi M; Ando T; Kohno K; Ogata M; Hiramatsu K; Kadota J
Intern Med; 2010; 49(13):1303-6. PubMed ID: 20606364
[TBL] [Abstract][Full Text] [Related]
19. Diffuse large B-cell lymphoma with germinal center B-cell phenotype mimicking primary effusion lymphoma.
Lim Y; Kim TY; Choi IS; Kim BS; Lee TS; Kim JE; Chang MS; Kim KH
J Clin Oncol; 2011 Apr; 29(10):e271-3. PubMed ID: 21220599
[No Abstract] [Full Text] [Related]
20. Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphoma.
Furman RR; Martin P; Ruan J; Cheung YK; Vose JM; LaCasce AS; Elstrom R; Coleman M; Leonard JP
Cancer; 2010 Dec; 116(23):5432-9. PubMed ID: 20665890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
